A pharmaceutical shipment is held at a port far more often for a paperwork error than for a quality problem. A misspelled consignee name, a missing signature, an expired certificate — any of these can hold a container for weeks.
Pharma export documentation is also cumulative. Customs wants one set, the drug regulator wants another, the bank under a letter of credit wants a third, and the three sets overlap without ever being identical.
This guide groups the documents by purpose: commercial, transport, regulatory and quality, origin and compliance, and payment. For each one you get what it is, who issues it, why it is needed, and the mistake that most often causes trouble.
Country rules change, so treat everything here as what is commonly required. Confirm the final list with the destination drug authority and the importer’s customs broker before you ship.
What documents are required for pharmaceutical export? Pharma export documentation usually includes a commercial invoice, packing list, bill of lading or airway bill, shipping bill, certificate of analysis, Certificate of Pharmaceutical Product, GMP certificate, manufacturing or drug licence, free sale certificate, certificate of origin, and any payment documents the buyer’s letter of credit calls for.
Table of Contents
- How the Document Set Fits Together
- Commercial Documents
- Transport Documents
- Regulatory and Quality Documents
- Origin and Compliance Documents
- Payment Documents
- Master Summary Table
- Which Documents Need Legalisation or Apostille
- How Requirements Vary by Destination Market
- Expert Tips
- Common Mistakes
- Frequently Asked Questions
<a id=”how-it-fits”></a>
How the Pharma Export Documentation Set Fits Together
Four different readers check your documents, and each one is looking for something else.
Customs at origin wants to confirm what is leaving the country, its value, and that the exporter is licensed to send it. Customs at destination wants to classify the goods, assess duty, and confirm the importer may receive them.
The drug regulator at destination ignores value entirely. It wants proof that the product is legally made, legally sold in the exporting country, and matches what was registered.
The bank reads the documents as a contract. Under a letter of credit it checks them against the credit terms, word by word, and pays or refuses on that basis alone.
One physical shipment therefore generates a document set that must be internally consistent. The product name, batch number, quantity, and consignee should be identical everywhere they appear. This sounds obvious and it is the single most common failure point.
<a id=”commercial”></a>
Commercial Documents
These establish the deal: what is being sold, at what price, on what terms, and in what packs.
Proforma Invoice
What it is: A preliminary invoice issued before the order is confirmed. It states product, quantity, price, Incoterm, payment terms, and validity.
Who issues it: The exporter.
Why it is needed: The importer uses it to apply for an import permit, open a letter of credit, or get internal purchase approval. Many drug authorities ask for it when issuing an import licence.
Common mistake: Leaving the validity date off, or setting it too long. Prices for APIs move, and an open-ended proforma invoice becomes a commitment you did not intend to make.
Commercial Invoice
What it is: The final bill for the goods. It carries the value that customs uses to assess duty and that the bank uses to release payment.
Who issues it: The exporter, after the order is confirmed and goods are ready.
Why it is needed: Customs at both ends need it for valuation and classification. It is the anchor document of the whole set.
Common mistake: A description that does not match the transport document or the letter of credit. Under an LC, “Paracetamol IP 500mg Tablets” and “Paracetamol Tablets 500mg” can be treated as a discrepancy.
Packing List
What it is: A carton-by-carton breakdown — batch numbers, quantity per carton, net and gross weight, dimensions, and shipping marks.
Who issues it: The exporter, usually the packing or dispatch department.
Why it is needed: Customs inspectors use it to verify a physical count without opening every carton. The importer uses it to check receipt and to reconcile batches against the certificate of analysis.
Common mistake: Omitting batch numbers. A pharmaceutical packing list without batch and expiry data is close to useless for the importer’s goods receipt and for any later recall.
Purchase Order
What it is: The buyer’s formal instruction to supply, referencing the proforma invoice.
Who issues it: The importer.
Why it is needed: It is the exporter’s authority to manufacture or allocate stock, and it is the reference point if a dispute arises over quantity or specification.
Common mistake: Accepting a purchase order that differs from the proforma invoice without issuing a revised proforma. The two documents then disagree, and the bank or customs will notice.
Sales Contract
What it is: A signed agreement covering terms the invoice cannot hold — minimum shelf life on arrival, quality responsibilities, rejection procedure, governing law, and force majeure.
Who issues it: Both parties.
Why it is needed: It decides who pays when something goes wrong. Some authorities also ask for a supply agreement during product registration.
Common mistake: Not specifying remaining shelf life at the time of delivery. Without a clause, a buyer can reject stock that arrived with less life than expected, and neither side has a written position.
<a id=”transport”></a>
Transport Documents
These prove the goods were handed to a carrier and set out who may claim them.
Bill of Lading or Airway Bill
What it is: The carrier’s receipt and contract of carriage. A sea bill of lading is usually a document of title — whoever holds the original endorsed set can claim the cargo. An airway bill is a receipt only, not a title document.
Who issues it: The shipping line, airline, or their freight forwarder.
Why it is needed: The importer cannot take delivery without it. Under an LC, it is the document the bank scrutinises most closely.
Common mistake: Consigning an airway bill directly to the buyer when payment has not been received. Since an airway bill is not a title document, the buyer can collect the goods without paying.
Shipping Bill
What it is: The export declaration filed with customs at origin, covering product details, value, HS code, and exporter licence references.
Who issues it: The exporter’s customs broker files it; customs grants the “let export” order.
Why it is needed: Without it the goods cannot legally leave. It also underpins the exporter’s later claim to a bank realisation certificate and any export incentives.
Common mistake: Using a generic HS code for a pharmaceutical product. The classification affects duty at destination and any preferential tariff claim, and correcting it after filing is slow.
Insurance Certificate
What it is: Proof that the cargo is insured, showing the sum insured, the risks covered, and the claims agent at destination.
Who issues it: The insurance company or broker, arranged by whichever party the Incoterm makes responsible.
Why it is needed: Under CIF and CIP the exporter must provide it. Banks require it under an LC when the Incoterm places the duty on the seller.
Common mistake: Insuring for invoice value only. Most credits and trade practice expect 110% of CIF value, and a short-insured certificate is a discrepancy.
Delivery Note
What it is: A dispatch document accompanying the physical goods to the warehouse or first carrier, confirming what left the premises and when.
Who issues it: The exporter’s warehouse or logistics team.
Why it is needed: It closes the loop between the packing list and the actual handover, and forms part of the distribution record a GMP or GDP audit will look for.
Common mistake: Not recording temperature-monitoring device details on it. For cold chain shipments the delivery note is where the data logger serial number belongs.
<a id=”regulatory”></a>
Regulatory and Quality Documents
This group is what separates pharma export documentation from ordinary trade paperwork. Customs may release goods on the commercial set alone; the drug regulator will not.
Certificate of Analysis (COA)
What it is: The batch-specific test report — every specification tested, the method used, the result obtained, and the pass or fail against limits.
Who issues it: The manufacturer’s quality control laboratory, signed by an authorised person.
Why it is needed: The importer cannot release the batch for sale without it, and many authorities check it at the port. It is the primary evidence that this batch meets specification.
Common mistake: Sending a specification sheet instead of a batch certificate of analysis. A specification lists limits; a COA lists actual results for a named batch. The two are not interchangeable.
Certificate of Pharmaceutical Product (CoPP)
What it is: A certificate in the WHO format that confirms the product is authorised in the exporting country, that the manufacturing site complies with GMP, and gives the product’s composition and label details.
Who issues it: The national drug regulatory authority of the exporting country.
Why it is needed: It is the backbone of product registration in importing countries under the WHO Certification Scheme. Regulators use it to accept the exporting authority’s assessment rather than repeat it.
Common mistake: Applying for it too late. A CoPP is issued per product and per site and takes weeks to obtain. It cannot be arranged during the week the shipment is packed.
Free Sale Certificate
What it is: Confirmation that the product is freely sold in the exporting country’s domestic market, without restriction.
Who issues it: The drug authority, or in some cases a chamber of commerce, depending on the country and product.
Why it is needed: Several importing markets ask for it as a lighter alternative to a CoPP, particularly for products that are not fully registered dossiers.
Common mistake: Requesting one for a product made only for export. If it is not sold domestically, a free sale certificate cannot honestly be issued, and the importer needs a different route.
GMP Certificate
What it is: Evidence that the manufacturing site has been inspected and found compliant with good manufacturing practice, naming the site, the dosage forms covered, and the inspection date.
Who issues it: The inspecting regulatory authority.
Why it is needed: Importing regulators want proof the site is inspected, not self-declared. The scope matters — a certificate covering tablets does not cover injectables. Our guide to GMP, WHO-GMP, EU GMP and US FDA explains the differences between schemes.
Common mistake: Submitting a certificate whose scope does not include the product being shipped, or one that has expired between order and dispatch.
Manufacturing Licence and Drug Licence
What it is: The manufacturing licence permits the site to make specified categories of product. A drug licence, depending on the country, may separately cover sale, distribution, or export.
Who issues it: The state or national drug control authority.
Why it is needed: It is the legal basis on which every other document rests. Customs at origin may ask for it before granting export clearance.
Common mistake: Sending a licence without its product schedule. The schedule is the part that shows the specific product is covered, and reviewers reject licences submitted without it.
Product Registration or Marketing Authorisation
What it is: The destination country’s approval to place the product on its market, held by the importer or a local agent in most jurisdictions.
Who issues it: The importing country’s drug regulatory authority.
Why it is needed: Without it, a finished pharmaceutical usually cannot be imported for commercial sale at all. Registration numbers are quoted on the import documents.
Common mistake: Shipping before the registration number is confirmed in writing. Verbal assurance that approval is “expected next week” is not a document customs will accept.
Non-Conviction or Non-Prosecution Certificate
What it is: A declaration, sometimes counter-signed by the drug authority, stating that the manufacturer has not been convicted of offences under the exporting country’s drug legislation.
Who issues it: The manufacturer, often endorsed by the licensing authority.
Why it is needed: Several importing markets, especially in Africa, the Middle East and parts of Asia, ask for it during registration or tender participation.
Common mistake: Assuming it is a standard form. Wording requirements differ by importing authority, so ask the buyer for the exact template they need.
<a id=”origin”></a>
Origin and Compliance Documents
Certificate of Origin
What it is: A declaration of where the goods were manufactured. A non-preferential certificate simply states origin. A preferential certificate is issued under a trade agreement and lets the importer claim reduced duty.
Who issues it: A chamber of commerce or an authorised export body; preferential certificates follow a format set by the specific trade agreement.
Why it is needed: Customs uses it for duty assessment and for any origin-based restrictions. The preferential version can meaningfully reduce landed cost.
Common mistake: Applying for a non-preferential certificate when a preferential one was available. The importer loses the duty benefit, and it is rarely recoverable after clearance.
Material Safety Data Sheet (MSDS/SDS)
What it is: A safety document covering hazards, handling, storage, first aid, spill response, and transport classification. APIs and intermediates need one; finished packs in retail form often do not.
Who issues it: The manufacturer, prepared to a recognised format such as the GHS 16-section structure.
Why it is needed: Carriers, warehouses and customs use it to decide how the material may be handled and stored.
Common mistake: Letting it go stale. An SDS should reflect current classification, and an outdated sheet can cause a carrier to refuse the booking at the terminal.
Dangerous Goods Declaration
What it is: A declaration required when the shipment includes material classified as dangerous for transport — certain solvents, flammable APIs, or shipments packed with dry ice.
Who issues it: The shipper, signed by a person with valid dangerous goods training.
Why it is needed: Air and sea carriers are legally bound to refuse undeclared dangerous goods. Dry ice in a cold chain shipment is itself a declarable item.
Common mistake: Forgetting that the coolant is regulated even when the medicine is not. Dry ice quantity must be declared on the airway bill.
Phytosanitary and Fumigation Certificates
What it is: A phytosanitary certificate covers plant-derived material; a fumigation certificate confirms wooden pallets or crates were treated to the ISPM 15 standard.
Who issues it: A government plant protection agency, or an accredited fumigation agency.
Why it is needed: Herbal and botanical products may need the first. Any shipment on untreated wooden packaging risks refusal on the second.
Common mistake: Overlooking pallets. The medicine may need nothing, but the wood under it does, and quarantine authorities inspect it at arrival.
Legalisation, Apostille and Chamber Attestation
What it is: A chain of authentications that makes a document acceptable to a foreign government. Chamber attestation, then a foreign ministry, then in some cases the destination country’s embassy. An apostille is a single certificate that replaces the chain between countries party to the Hague Apostille Convention.
Who issues it: The chamber of commerce, the designated competent authority for apostilles, and the relevant embassy or consulate.
Why it is needed: Many importing authorities will not accept a foreign-issued certificate unless its signature has been verified through this chain.
Common mistake: Starting the process two weeks before shipment. Legalisation through an embassy commonly takes longer than manufacturing the batch.
<a id=”payment”></a>
Payment Documents
Letter of Credit
What it is: A bank undertaking to pay the exporter once compliant documents are presented. It shifts payment risk from the buyer to a bank.
Who issues it: The importer’s bank, usually advised or confirmed through a bank in the exporter’s country.
Why it is needed: It gives the exporter security on a first order and the importer assurance that payment is conditional on documents.
An LC typically calls for: signed commercial invoice, full set of bills of lading or the airway bill, packing list, insurance certificate where the Incoterm requires it, certificate of origin, certificate of analysis, and a beneficiary’s certificate confirming documents were couriered.
Common mistake: Not reviewing the LC on the day it arrives. Every unworkable term — an impossible shipment date, a certificate you cannot obtain — must be amended before goods move, not after.
Bill of Exchange
What it is: A written order from the exporter instructing the importer or their bank to pay a stated sum, either at sight or after an agreed period.
Who issues it: The exporter, drawn on the buyer or the issuing bank.
Why it is needed: It converts an invoice into a negotiable instrument, which matters for documentary collections and term credits.
Common mistake: Drawing it on the wrong party or for the wrong tenor. Under an LC the drawee is specified in the credit, and getting it wrong is a discrepancy.
Bank Realisation Certificate
What it is: Confirmation from the exporter’s bank that payment for a specific shipment was received from abroad.
Who issues it: The exporter’s bank, referencing the shipping bill.
Why it is needed: Exchange control and export incentive schemes in many countries require proof that export proceeds were repatriated.
Common mistake: Not linking the inward remittance to the correct shipping bill. Untagged remittances leave open export entries that surface in later audits.
<a id=”summary-table”></a>
Master Summary Table
| Document | Issued by | Required for | Typically needed when |
|---|---|---|---|
| Proforma invoice | Exporter | Import permit, LC opening | Every order, before confirmation |
| Commercial invoice | Exporter | Customs valuation, payment | Every shipment |
| Packing list | Exporter | Physical verification, goods receipt | Every shipment |
| Purchase order | Importer | Authority to supply | Every order |
| Sales contract | Both parties | Dispute and quality terms | Ongoing supply, large orders |
| Bill of lading / airway bill | Carrier or forwarder | Cargo release, LC presentation | Every shipment |
| Shipping bill | Customs at origin | Export clearance | Every shipment |
| Insurance certificate | Insurer | Risk cover, CIF/CIP terms | When seller insures, or LC requires |
| Delivery note | Exporter | Dispatch and GDP record | Every shipment |
| Certificate of analysis | Manufacturer’s QC lab | Batch release at destination | Every pharmaceutical batch |
| Certificate of Pharmaceutical Product | Exporting country’s drug authority | Product registration abroad | Registration, tenders, many regulated markets |
| Free sale certificate | Drug authority or chamber | Proof of domestic marketability | Where a CoPP is not demanded |
| GMP certificate | Inspecting authority | Site compliance evidence | Registration and most shipments |
| Manufacturing / drug licence | State or national authority | Legal basis to manufacture | Registration, export clearance |
| Product registration | Importing country’s authority | Legal import and sale | Finished products in regulated markets |
| Non-conviction certificate | Manufacturer, often endorsed | Regulator and tender screening | Certain African, Middle Eastern, Asian markets |
| Certificate of origin | Chamber of commerce | Duty assessment, tariff preference | Most shipments |
| MSDS / SDS | Manufacturer | Safe handling and transport | APIs, intermediates, bulk chemicals |
| Dangerous goods declaration | Shipper | Carrier acceptance | Hazardous items or dry ice |
| Phytosanitary / fumigation | Plant agency or fumigator | Quarantine clearance | Botanical goods, wooden packaging |
| Letter of credit | Importer’s bank | Payment security | Negotiated payment terms |
| Bill of exchange | Exporter | Negotiable payment instrument | Collections, term credits |
| Bank realisation certificate | Exporter’s bank | Proof of proceeds received | After payment, for exchange control |
<a id=”legalisation”></a>
Which Documents Commonly Require Legalisation or Apostille
Legalisation is applied to documents a foreign government must trust. Commercial documents rarely need it; regulatory ones frequently do.
The documents most often requiring authentication are the Certificate of Pharmaceutical Product, the free sale certificate, the GMP certificate, the manufacturing licence, the non-conviction certificate, and sometimes the certificate of origin and a power of attorney for a local agent.
Which route applies depends on the destination. Where both countries are party to the Hague Apostille Convention, a single apostille from the designated authority is usually enough. Where the destination is not a party, the older chain applies — notary or chamber, then foreign ministry, then embassy.
Documents for registration dossiers usually need originals with wet signatures and full legalisation. Documents supporting a routine repeat shipment are more often accepted as attested copies. Ask the importer which they need before paying for the harder version.
Plan around six to ten weeks for a full embassy legalisation chain and treat that as the long pole in any first shipment. Certificates also carry validity periods, so a certificate legalised too early can expire before the dossier is filed.
<a id=”by-market”></a>
How Requirements Vary by Destination Market
No two importing authorities ask for exactly the same set. The pattern below describes what is commonly seen, not a rule you can rely on without checking.
Highly regulated markets such as the EU, the US, Japan, Canada and Australia lean on the registration dossier rather than shipment certificates. Once a product is approved, routine shipments often need only the commercial and transport set plus the certificate of analysis. Our guide on importing pharmaceuticals into Europe covers that pathway in detail.
Emerging and semi-regulated markets across parts of Africa, Southeast Asia and Latin America usually rely more heavily on the WHO Certification Scheme. Expect a CoPP, GMP certificate, free sale certificate and legalisation to be central to both registration and clearance.
Gulf and Middle East markets commonly require embassy legalisation and sometimes attested Arabic translations. Several also operate price-registration systems, so the invoice value may be checked against a filed reference price.
Tender and institutional supply to government or donor-funded programmes adds another layer — bid bonds, manufacturer authorisation letters, batch pre-shipment inspection reports, and non-conviction certificates.
Three habits keep this manageable. Ask the importer for a written document checklist at quotation stage. Confirm it against the destination authority’s published guidance. Then re-confirm before each shipment, because requirements change without much notice.
<a id=”expert-tips”></a>
Expert Tips for Managing Pharma Export Documentation
- Build a document matrix per country, not per order. Keep one sheet per destination listing every document, its issuer, its lead time, and its validity. It turns a scramble into a checklist.
- Track expiry dates like stock. GMP certificates, licences and CoPPs all expire. Set a reminder ninety days out; renewal is slower than you expect and no buyer accepts an expired certificate.
- Freeze the product description early. Agree one exact wording — name, strength, form, pharmacopoeial standard — and use it identically on the invoice, packing list, transport document and LC. Most LC discrepancies come from small wording drift.
- Send draft documents for approval before finalising. Email PDF drafts of the invoice, packing list and certificate of analysis to the importer and their broker. Fixing a draft costs nothing; amending an issued bill of lading costs money and days.
- Start legalisation before the batch is made. Authentication runs on government timelines that are independent of your production schedule, so it should be the first task on a new-market order, not the last.
- Keep a scanned archive indexed by batch and shipment. When a query comes eighteen months later, you need the exact set that travelled with that consignment, not the current version of each template.
- Read the letter of credit the day it arrives. Check dates, document list, description and drawee against what you can actually produce. Request amendments immediately, while the buyer is still motivated to help.
<a id=”common-mistakes”></a>
Common Documentation Mistakes in Pharmaceutical Export
- Inconsistent product descriptions across documents. The bank raises a discrepancy and payment stalls until the buyer waives it, which they may use as leverage.
- Missing batch numbers on the packing list. The importer cannot reconcile stock against the certificate of analysis, delaying goods receipt and local release.
- Sending a specification sheet in place of a certificate of analysis. The batch cannot be released at destination, and the goods sit in a bonded warehouse accruing charges.
- Applying for a CoPP or legalisation after production is complete. The shipment waits weeks for paper while shelf life runs down.
- Consigning an airway bill directly to an unpaid buyer. The goods can be collected without payment, and the exporter has lost their leverage entirely.
- Using an untreated wooden pallet without a fumigation certificate. Quarantine can refuse or order re-packing at destination, at the exporter’s cost.
- Insuring at 100% of invoice value under an LC. The presentation is discrepant and the underinsured portion is uncovered if there is a claim.
<a id=”faq”></a>
Frequently Asked Questions
What documents are required for pharmaceutical export?
Most shipments need a commercial invoice, packing list, transport document such as a bill of lading or airway bill, shipping bill, and certificate of analysis for each batch. Regulated destinations add a Certificate of Pharmaceutical Product, GMP certificate, manufacturing or drug licence, free sale certificate, and evidence of product registration. Origin and compliance documents such as a certificate of origin and an MSDS apply depending on the product. Payment documents follow the agreed terms. The exact list varies by destination, so confirm it with the importing authority.
What is a Certificate of Pharmaceutical Product?
A CoPP is a certificate issued in the WHO format by the drug regulatory authority of the exporting country. It confirms the product is authorised there, states whether it is marketed domestically, gives the composition and label details, and confirms the manufacturing site is inspected for GMP compliance. Importing regulators rely on it to accept the exporting authority’s assessment rather than repeating the review. It is issued per product and per site, takes weeks to obtain, and is central to registration in markets that follow the WHO Certification Scheme.
What is the difference between a free sale certificate and a CoPP?
Both confirm a product’s standing in the exporting country, but they differ in depth. A free sale certificate simply states that the product is sold freely in the domestic market without restriction. A CoPP is far more detailed, following a fixed WHO format that covers marketing authorisation status, composition, labelling, and GMP compliance of the named manufacturing site. Regulators in stringent markets usually want a CoPP. Some importing authorities accept a free sale certificate as a lighter alternative, particularly where a full registration dossier is not being filed.
Do I need a certificate of analysis for every shipment?
Yes, and for every batch within a shipment. A certificate of analysis is batch-specific, listing the actual test results obtained for that batch against its specification. The importer’s qualified person or equivalent needs it before releasing the batch for sale, and customs or the drug inspector may ask for it at the port. A product specification sheet is not a substitute, because it shows limits rather than results. Make sure the batch numbers on the certificate of analysis match the packing list exactly.
Which pharmaceutical export documents need an apostille?
Regulatory certificates are the ones that usually need authentication. The Certificate of Pharmaceutical Product, free sale certificate, GMP certificate, manufacturing licence, non-conviction certificate and any power of attorney for a local agent are the common candidates. Where both countries are party to the Hague Apostille Convention, a single apostille normally suffices. Otherwise the older chain applies: chamber or notary, then foreign ministry, then embassy of the destination country. Requirements differ by market and change over time, so confirm the route with the destination authority or the importer before starting.
What is the difference between a bill of lading and an airway bill?
A bill of lading is issued for sea freight and is usually a document of title, meaning whoever holds the original endorsed set can claim the cargo. That makes it useful as payment security, since the exporter can withhold originals until paid. An airway bill is issued for air freight and is a receipt and contract of carriage only, not a document of title. The consignee named on it can collect the goods without presenting an original. For unpaid air shipments, consign to a bank rather than directly to the buyer.
Who issues the certificate of origin for pharmaceutical exports?
A chamber of commerce or another authorised export body issues it, based on a declaration from the exporter. There are two types. A non-preferential certificate simply states the country of manufacture and supports customs classification. A preferential certificate is issued under a specific trade agreement and allows the importer to claim a reduced duty rate, so it follows the format that agreement prescribes. Check whether a trade agreement covers your route before applying, because the duty saving is usually not recoverable after clearance.
How long before shipment should export documents be prepared?
Split them into two groups. Regulatory documents such as a CoPP, GMP certificate and anything requiring legalisation should be started months ahead, ideally before manufacturing begins, since government timelines are outside your control. Commercial and transport documents are prepared in the final week, once batch numbers and pack details are fixed. Send drafts of the invoice, packing list and certificate of analysis to the importer and their broker for approval a few days before dispatch, so errors are corrected on paper rather than at the port.
What documents does a letter of credit usually require?
Most credits covering pharmaceutical shipments call for a signed commercial invoice, a full set of bills of lading or the airway bill, a packing list, a certificate of origin, and a batch certificate of analysis. An insurance certificate is added when the Incoterm places cover on the seller, commonly for 110% of CIF value. Many credits also ask for a beneficiary’s certificate confirming that copy documents were couriered to the buyer. Read the credit as soon as it arrives and request amendments for any term you cannot meet.
Can pharmaceutical goods be exported without product registration in the destination country?
Usually not for finished products intended for commercial sale, since most authorities require a marketing authorisation held by a local entity. There are recognised exceptions. APIs supplied to a licensed manufacturer for further processing generally follow a different route. Clinical trial material, named-patient supply, government emergency imports and samples for registration testing are often handled under specific permits. Each exception has its own paperwork and quantity limits. Confirm the pathway in writing with the destination authority before shipping anything on the assumption that an exception applies.
Final Thoughts
Documentation is where pharmaceutical export deals are actually won or lost. The commercial terms take a week to agree; the certificates and their legalisation can take months.
Treat pharma export documentation as a project with its own timeline, owner, and expiry tracker. Confirm the list with the destination authority for every new market, and re-check it before each shipment.
Discuss Your Sourcing Requirements
If you are planning a first shipment into a new market, speak with our pharmaceutical experts about the document set your destination is likely to ask for. Share your product, target country and timeline, and we will map the paperwork and its realistic lead times before you commit to an order.